MedPath

Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging

Terminated
Conditions
Abnormalities, Cardiovascular
Registration Number
NCT00593541
Lead Sponsor
University of California, Davis
Brief Summary

This Protocol is intended to facilitate development and testing of new cardiovascular MRI software capabilities by UC Davis Research Faculty, as well as to facilitate the evaluation of new software capabilities provided by GE and Siemens.

Detailed Description

This protocol will permit normal subjects, as well as patients with suspected or proven medical conditions, to undergo MRI studies using the new software capabilities. This Protocol is not restricted to imaging of a particular organ system or disease. The Protocol does not involve injection of any contrast agent, or other minimally-invasive or invasive procedure. It is intended only for those cases for which the only requirement of the subject is to relax and lie still while imaging is being performed.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • 18 years of age or older
  • Ability to give informed, written consent
  • Not Pregnant or breastfeeding
Exclusion Criteria
  • Electrically, magnetically, or mechanically activated implants (for example, cardiac-pacemakers)
  • Ferromagnetic implant, such as an aneurysm clip, surgical clip, or prosthesis
  • History of uncontrolled claustrophobia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Extend or generalize certain capabilities, such as new data acquisition pulse sequences, new image processing and analysis software for structural and functional analysis of the MR imagesPost-scanning
Secondary Outcome Measures
NameTimeMethod
Improve image quality by various techniques (e.g. reducing the effects of motion)Post-scanning
© Copyright 2025. All Rights Reserved by MedPath